Metastatic Gastrointestinal Cancer: Safety of Cisplatin Combined with Continuous 5-FU Versus Bolus 5-FU and Leucovorin (Methodology)-Reference-Cited by-同舟云学术

Metastatic Gastrointestinal Cancer: Safety of Cisplatin Combined with Continuous 5-FU Versus Bolus 5-FU and Leucovorin (Methodology)

Published:2008 Issue: Volume: Page:13-21
ISSN:
Container-title:Gastrointestinal Carcinoma
language:
Short-container-title:

Author:

Duffour Jacqueline,Bouché Olivier,Rougier Philippe,Milan Chantal,Bedenne Laurent,Seitz Jean-François,Buecher Bruno,Legoux Jean-Louis,Ducreux Michel,Vetter Denis,Raoul Jean-Luc,François Eric,Ychou Marc

Publisher

Springer Netherlands

Link

http://link.springer.com/content/pdf/10.1007/978-1-4020-8900-8_2

Reference19 articles.

1. Andre, T., Lotz, J.P., Bouleuc, C., Azzouzi, K., Houry, S., Hannoun, L., See, J., Esteso, A., Avenin, D., and Izrael, V. 1996. Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. Ann. Oncol. 7: 173–178.

2. Bleiberg, H., Conroy, T., Paillot, B., Lacave, A.J., Blijham, G., Jacob, J.H., Bedenne, L., Namer, M., De Besi, P., Gay, F., Collette, L., and Sahmoud, T. 1997. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur. J. Cancer 33: 1216–1220.

3. Bouché, O., Raoul, J.L., Bonnetain, F., Giovannini, M., Etienne, P.L., Lledo, G., Arsene, D., Paitel, J.F., Guerin-Meyer, V., Mitry, E., Buecher, B., Kaminsky, M.C., Seitz, J.F., Rougier, P., Bedenne, L., and Milan, C. 2004. Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancerologie Digestive Group Study-FFCD 9803. J. Clin. Oncol. 22: 4319–4328.0

4. Colucci, G., Giuliani, F., Gebbia, V., Biglietto, M., Rabitti, P., Uomo, G., Cigolari, S., Testa, A., Maiello, E., and Lopez, M., 2002. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell’Italia Meridionale. Cancer 94: 902–910.

5. Ducreux, M., Rougier, P., Pignon, J.P., Douillard, J.Y., Seitz, J.F., Bugat, R., Bosset, J.F., Merouche, Y., Raoul, J.L., Ychou, M., Adenis, A., Berthault-Cvitkovic, F., and Luboinski, M. 2002. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann. Oncol. 13: 1185–1191.